Single User License
INR 203720
Site License
INR 407440
Corporate User License
INR 611160

Service Tax Additional

select a format
Price

Single User License
USD 2995
Site License
USD 5990
Corporate User License
USD 8985

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Life Cycle Management Strategies-Optimizing revenues and defending generic competition

Life Cycle Management Strategies-Optimizing revenues and defending generic competition


  Request for Sample Report

Executive Summary

Life Cycle Management Strategies-Optimizing revenues and defending generic competition GBI Research's latest report, "Life Cycle Management Strategies-Optimizing revenues and defending generic competition" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on. Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma. Scope Introduction of LCM and product life cycle Objectives of LCM and factors impacting the choice of strategies LCM strategies depending on the way of approach Impact of LCM strategies on sales and growth trend of selected products Patent term extension and market exclusivity in the US and Europe LCM strategies of pipeline drugs of key players Keys to successful implementation of LCM strategies Reasons To Buy Identify the key LCM strategies used by most of the pharmaceutical companies Analyze the strategies to increase lifecycle and revenues of a drug Gain an understanding on the implementation of multiple strategies for a single product by including case studies Understand the operational pipeline strategies of key players

Executive Summary Introduction Overview of Product Life Cycle Product Life Cycle Curve Objectives of Life Cycle Management (LCM) Classification and Benefits of LCM Strategies Strategic Planning for LCM Factors Impacting Choice of LCM Strategies Developmental Strategies Indication Expansion/Sequencing and Repositioning Patient Subpopulations and Personalized Medicine Reformulation New Dosage Forms New Route of Administration Special Cases New Dosage Strengths and Regimen Fixed-Dose Combination and Co-packaging Next Generation Products and Modified Chemistry Metabolites Chiral Switching Polymorphs Multiple Developmental Strategy Approach Commercial Strategies Rx-to-OTC/BTC Switch Geographical Expansion Pricing Strategy and Tactics Pricing Strategy for Targeting Multiple Indications Coupons Co-pay Cards Awareness, Brand Loyalty and Service Programs Regulatory and Legal Strategies Authorized Generics Legal Defense and Pay for Delay Citizen's Petition Patent Term Extension and Market Exclusivity The Pharmaceutical Pipeline and LCM Successful Implementation of LCM Strategies Appendix

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma

Lifecycle management


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com